ALFF Value in Right Parahippocampal Gyrus Acts as a Potential Marker Monitoring Amyotrophic Lateral Sclerosis Progression: a Neuropsychological, Voxel-Based Morphometry, and Resting-State Functional MRI Study

Journal of Molecular Neuroscience

Volumn 57, Issue 1, 2015, Pages 106-113

  Zhu, Wenjia ^a   Fu, Xiaoling ^b   Cui, Fang ^a   Yang, Fei ^a   Ren, Yuting ^a   Zhang, Xiaoyun ^c   Zhang, Xiaolan ^a   Chen, Zhaohui ^a   Ling, Li ^a   Huang, Xusheng ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b The First Affiliated Hospital of General Hospital of the Chinese People's Liberation Army   (China)

^c 306 HOSPITAL OF PLA   (China)

Author keywords

Amyotrophic lateral sclerosis; Cognition; Resting state functional magnetic resonance imaging; Voxel based morphometry

Indexed keywords

ADULT; AMPLITUDE OF LOW FREQUENCY FLUCTUATION; AMYOTROPHIC LATERAL SCLEROSIS; ANTERIOR CINGULATE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; COGNITION ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FRONTAL ASSESSMENT BATTERY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; INFERIOR TEMPORAL GYRUS; LEFT HEMISPHERE; MALE; MIDDLE AGED; MIDDLE OCCIPITAL GYRUS; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARAHIPPOCAMPAL GYRUS; PATIENT MONITORING; RESTING STATE NETWORK; RIGHT HEMISPHERE; STROOP TEST; SUPERIOR FRONTAL GYRUS; VOXEL BASED MORPHOMETRY; WISCONSIN CARD SORTING TEST; CASE CONTROL STUDY; EXECUTIVE FUNCTION; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; EXECUTIVE FUNCTION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARAHIPPOCAMPAL GYRUS;

EID: 84939568762     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-015-0583-9     Document Type: Article

References (34)

1. Achi EY, Rudnicki SY (2012) ALS and frontotemporal dysfunction: a review. Neurol Res Int 2012:806306
2. Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38:95–113
3. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26:839–851
4. Benatar M, Wuu J (2012) Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology 79:1732–1739
5. Bede P, Bokde A, Elamin M, Byrne S, McLaughlin RL, Jordan N, Hampel H, Gallagher L, Lynch C, Fagan AJ, Pender N, Hardiman O (2013) Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality.J Neurol Neurosurg Psychiatry. 84(7):766–773
6. Bowser R, Turner MR, Shefner J (2011) Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nat Rev Neurol 7:631–638
7. Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ, Del Tredici KD (2013) Amyotrophic lateral sclerosis–a model of corticofugal axonal spread. Nat Rev Neurol 9:708–714
8. Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 1:293–299
9. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169:13–21
10. Crespi C, Cerami C, Dodich A, Canessa N, Arpone M, Iannaccone S, Corbo M, Lunetta C, Scola E, Falini A, Cappa SF (2014) Microstructural white matter correlates of emotion recognition impairment in amyotrophic lateral sclerosis. Cortex 53:1–8
11. Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB a frontal assessment battery at bedside. Neurology 55:1621–1626
12. Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, O’Brien C, Phukan J, Lynch C, Pender N, Hardiman O (2013) Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 80:1590–1597
13. Foerster BR, Welsh RC, Feldman EL (2013) 25 years of neuroimaging in amyotrophic lateral sclerosis. Nat Rev Neurol 9:513–524
14. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
15. Goldstein LH, Abrahams S (2013) Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol 12:368–380
16. Jouroukhin Y, Ostritsky R, Gozes I (2012) D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy. J Mol Neursci 48(3):597–602
17. Lakerveld J, Kotchoubey B, Kubler A (2008) Cognitive function in patients with late stage amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 79:25–29
18. Luo C, Chen Q, Huang R, Chen X, Chen K, Huang X, Tang H, Gong Q, Shang HF (2012) Patterns of spontaneous brain activity in amyotrophic lateral sclerosis: a resting-state FMRI study. PLoS One 7, e45470
19. Machts J, Bittner V, Kasper E, Schuster C, Prudlo J, Abdulla S, Kollewe K, Petri S, Dengler R, Heinze HJ (2014) Memory deficits in amyotrophic lateral sclerosis are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairment. BMC Neurosci 15:83
20. MacLeod CM (1991) Half a century of research on the Stroop effect: an integrative review. Psychol Bull 109:163–203
21. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699
22. Nicholas JA, Boster AL, Imitola J, O’Connell C, Racke MK (2014) Design of oral agent for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate. Drug Des Devel Ther 8:897–908
23. Rajagopalan V, Pioro EP (2014) Distinct patterns of cortical atrophy in ALS patients with or without dementia: an MRI VBM study. Amyotroph Lateral Scler Frontotemporal Degener 15:3–4
24. Strong MJ, Yang W (2011) The frontotemporal syndromes of ALS. Clinicopathological correlates. J Mol Neurosci 45(3):648–655
25. Takeda T, Uchihara T, Mochizuki Y, Mizutani T, Iwata M (2007) Memory deficits in amyotrophic lateral sclerosis patients with dementia and degeneration of the perforant pathway a clinicopathological study. J Neurol Sci 260:225–230
26. Taverniers J, Taylor MK, Smeets T (2013) Delayed memory effects after intense stress in special forces candidates: exploring path processes between cortisol secretion and memory recall. Stress 16:311–320
27. Trojsi F, Esposito F, de Stefano M, Buonanno D, Conforti FL, Corbo D, Piccirillo G, Cirillo M, Monsurrò MR, Montella P (2015) Functional overlap and divergence between ALS and bvFTD. Neurobiol Aging 36:413–423
28. Tsermentseli S, Leigh PN, Goldstein LH (2012) The anatomy of cognitive impairment in amyotrophic lateral sclerosis: more than frontal lobe dysfunction. Cortex 48:166–182
29. Turner MR, Modo M (2010) Advances in the application of MRI to amyotrophic lateral sclerosis. Expert Opin Med Diagn 4:483–496
30. Turner MR, Agosta F, Bede P, Govind V, Lule D, Verstraete E (2012) Neuroimaging in amyotrophic lateral sclerosis. Biomark Med 6:319–337
31. Veale JF (2014) Edinburgh handedness inventory - short form: a revised version based on confirmatory factor analysis. Laterality 19:164–177
32. Wang M, Ma H, Huang YL, Zhu G, Zhao JP (2014) Association of neurotensin receptor 1 gene polymorphisms with processing speed in health Chinese-Han subjects. J Mol Neurosci 54(4):787–789
33. Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M, Rutherford NJ, Baker M, Knopman DS, Wszolek ZK, Parisi JE, Dickson DW, Petersen RC, Rademakers R, Jack CR, Josephs KA (2012) Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain 135:794–806
34. Zhang YF, He Y, Zhu CZ, Cao QJ, Sui MQ, Liang M, Tian LX, Jiang XZ, Wang YF (2007) Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI. Brain Dev 29(2):83–91